| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55513-112-01 | 55513-112 | HUMAN PRESCRIPTION DRUG | TEZSPIRE | tezepelumab-ekko | INJECTION, SOLUTION | SUBCUTANEOUS | 20211217 | N/A | BLA | BLA761224 | Amgen Inc | TEZEPELUMAB | 210 mg/1.9mL | 1 SYRINGE in 1 CARTON (55513-112-01) / 1.91 mL in 1 SYRINGE |
| 55513-112-96 | 55513-112 | HUMAN PRESCRIPTION DRUG | TEZSPIRE | tezepelumab-ekko | INJECTION, SOLUTION | SUBCUTANEOUS | 20211217 | N/A | BLA | BLA761224 | Amgen Inc | TEZEPELUMAB | 210 mg/1.9mL | 1 SYRINGE in 1 CARTON (55513-112-96) / 1.91 mL in 1 SYRINGE |
| 55513-112-99 | 55513-112 | HUMAN PRESCRIPTION DRUG | TEZSPIRE | tezepelumab-ekko | INJECTION, SOLUTION | SUBCUTANEOUS | 20211217 | N/A | BLA | BLA761224 | Amgen Inc | TEZEPELUMAB | 210 mg/1.9mL | 1.91 mL in 1 SYRINGE (55513-112-99) |
| 55513-123-01 | 55513-123 | HUMAN PRESCRIPTION DRUG | TEZSPIRE | tezepelumab-ekko | INJECTION, SOLUTION | SUBCUTANEOUS | 20230214 | N/A | BLA | BLA761224 | Amgen Inc | TEZEPELUMAB | 210 mg/1.9mL | 1 CARTRIDGE in 1 CARTON (55513-123-01) / 1.91 mL in 1 CARTRIDGE |
| 55513-123-96 | 55513-123 | HUMAN PRESCRIPTION DRUG | TEZSPIRE | tezepelumab-ekko | INJECTION, SOLUTION | SUBCUTANEOUS | 20240220 | N/A | BLA | BLA761224 | Amgen Inc | TEZEPELUMAB | 210 mg/1.9mL | 1 CARTRIDGE in 1 CARTON (55513-123-96) / 1.91 mL in 1 CARTRIDGE |